Nano-X Imaging Ltd. (NNOX): Price and Financial Metrics
GET POWR RATINGS... FREE!
NNOX Stock Price Chart Interactive Chart >
NNOX Price/Volume Stats
|Current price||$29.67||52-week high||$94.81|
|Prev. close||$28.66||52-week low||$19.05|
|Day high||$29.77||Avg. volume||2,298,252|
|50-day MA||$30.37||Dividend yield||N/A|
|200-day MA||$41.37||Market Cap||1.41B|
Nano-X Imaging Ltd. (NNOX) Company Bio
Nano-X Imaging Ltd. engages in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository; radiologist matching; online and offline diagnostics review and annotation; connectivity to diagnostic assistive artificial intelligence systems; billing; and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya on December 20, 2018 and is headquartered in Neve Ilan, Israel.
NNOX Latest News Stream
|Loading, please wait...|
NNOX Latest Social Stream
View Full NNOX Social Stream
Latest NNOX News From Around the Web
Below are the latest news stories about Nano-X Imaging Ltd that investors may wish to consider to help them evaluate NNOX as an investment opportunity.
NEVE ILAN, Israel, May 26, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox’s Chairman and Chief Executive Officer Ran Poliakine will make a company presentation and the leadership team will host investor 1x1 meetings during the Jefferies Virtual Healthcare Conference, which is being held June 1st through June 4th. Mr. Poliakine’s presentation is scheduled for Thursday, June 3, at 4:30pm ET. The presentation will be accessible via a live webcast at: https://wsw.com/webcast/jeff174/nani/1840266 Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company's website at www.nanox.vision. The webcast replay will...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Photo by Luis Alvarez/DigitalVision via Getty Images Development phase X-ray technology company Nano-X Imaging Ltd. (NNOX) recently issued Q1 results for the 2021 fiscal year, as well as an update on upcoming milestones within the business. Investors were notified that the company's plan to ship 1,000 of its multi-source X-ray...
On today's call, we will hear from Ran Poliakine, chairman of the board of directors and chief executive officer; and Itzhak Maayan, chief financial officer. Thank you, Glenn, and thanks to everyone joining our first-quarter update call.
Nano-X Imaging (NASDAQ: NNOX ) reported a first-quarter net loss of $12.7 million wider than $7.4 million reported a year ago. It clocked an adjusted net loss of $7.1 million, or EPS loss of ($0.15) better than the consensus of ($0.25) loss. In the prior-year period, Nano-X recorded an EPS loss of ($0.09). R&D expenses increased slightly to $2.7 million Y/Y from $2.4 million last year due to higher development costs related to the Nano-X System. Nano-X received FDA clearance for its single-source Nano-X Cart X-Ray System in April. It viewed this achievement as a key milestone on its path to win a … Full story available on Benzinga.com
NNOX Price Returns